Přejít k hlavnímu obsahu
Obrázek záhlaví
User picture
Akademický titul: Mgr.
Skupiny: BAKALÁŘSKÝ STUDENT, DOKTORSKÝ STUDENT, IMTM, LEM, MAGISTERSKÝ STUDENT, PERSONÁL

Doktorské studium

Multimodal imaging methods for preclinical testing of novel bioactive molecules

Specializace: Molekulární a translační medicína
Stav: Ongoing od 2023.

Magisterské studium

New PSMA ligands for prostate cancer diagnosis and therapy

Stav: Absolvoval od 2021 do 2023.

Bakalářské studium

Nanoparticles for detection of sentinel lymph nodes

Stav: Graduated od 2019 do 2021.

O mně

My diploma thesis  was focused on new radioactive labelled PSMA ligands for therapy and imaging of prostate cancer, where we used human prostate cancer xenografts in mice. We established  basic in vitro and in vivo charasterictics of these compounds such as Stability in human blood, hydrophophicity, rate of binding to human blood. We used modalities such as HPLC with radiodetector, PET-CT and for detection of radioactivity in organs we used gamma counter. As a part of my doctoral trainig my focus is on testing another compounds which can be used for radiolabelled multimodal imaging and therapy. 

Journals

KRASULOVÁ, K., B. NEUŽILOVÁ, K. DVOŘÁKOVÁ BENDOVÁ, K. HAJDUOVÁ, P. MLYNÁRČIK, M. POPPER, M. HAJDÚCH, M. PETŘÍK
Targeted PET Imaging of Pseudomonas aeruginosa Using a [68Ga]Ga-Pyoverdines Cocktail. Journal of Nuclear Medicine : official publication, Society of Nuclear Medicine. 2026, jnumed.125.271909, ISSN: 0161-5505, PMID: 42595487,  PDF.
HAJDUOVÁ, K., K. DVOŘÁKOVÁ BENDOVÁ, M. PETŘÍK, M. BENESOVA-SCHAFER, M. SCHAFER, M. HAJDÚCH, Z. NOVÝ
Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modifications. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 63, ISSN: 2365-421X, PMID: 41003962,  PDF.
TROMMER, J., M. ULLRICH, F. REISSIG, S. BRUHLMANN, A. NITT-WEBER, Z. NOVÝ, K. HAJDUOVÁ, D. KURFÜRSTOVÁ, R. HENDRYCHOVÁ, J. BOUCHAL, M. PETŘÍK, C. NEUBER, W. SIHVER, S. STADLBAUER, J. PIETZSCH, M. KRELLER, K. KOPKA, C. MAMAT, K. ZARSCHSLER
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 31, ISSN: 2365-421X, PMID: 40536585,